Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Perrigo CoPRGO +1.26%44 EV-to-OCF is 24.91 as of Jul. 29, 2026, which is 18% above its 10-year median of 21.06. GuruFocus rates PRGO with a GF Score™ of 44/100 and a GF Value™ of $24.91 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Perrigo Co ranks worse than 75.3% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Perrigo Co's Enterprise Value is $4,718 Mil.
Perrigo Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $189 Mil. Therefore, Perrigo Co's EV-to-OCF for today is 24.91.
The historical rank and industry rank for Perrigo Co's EV-to-OCF or its related term are showing as below:
PRGO'
s EV-to-OCF Range Over the Past 10 Years
Min: 12.85 Med: 21.06 Max: 570.2
Current: 24.91
During the past 13 years, the highest EV-to-OCF of Perrigo Co was 570.20. The lowest was 12.85. And the median was 21.06.
PRGO's EV-to-OCF is ranked worse than 75.3% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 10.545
vs PRGO: 24.91
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Perrigo Co's share price for today is $10.43.
Perrigo Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.100.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Perrigo Co EV-to-OCF Related Terms
Perrigo Co EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Perrigo Co's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Perrigo Co's EV-to-OCF falls into.
Perrigo Co's current Enterprise Value is $4,718 Mil.
Perrigo Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $189 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (PRGO) has a EV-to-OCF of 24.91 as of Jul. 29, 2026. This is 18% above median its historical median of 21.06. Over the past decade, Perrigo Co's EV-to-OCF has ranged from 12.85 to 570.20. According to the industry distribution chart, Perrigo Co ranks #759 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 75.3%.
Is Perrigo Co's EV-to-OCF too high?
Perrigo Co's current EV-to-OCF of 24.91 is 18% above median its 10-year median of 21.06. Over the past 10 years, this metric has ranged from a low of 12.85 to a high of 570.20. The Drug Manufacturers industry median EV-to-OCF is 10.55. Perrigo Co's value of 24.91 is 136.2% above this industry median. Based on the distribution chart, Perrigo Co ranks #759 out of 1008 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Perrigo Co has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's EV-to-OCF compare to PAHC and HROW?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #759 out of 1008 companies for EV-to-OCF. This places Perrigo Co in the lower half of its industry. The industry median EV-to-OCF is 10.55. Perrigo Co's value of 24.91 is 136.2% above this benchmark. Historically, Perrigo Co's own EV-to-OCF has ranged from 12.85 to 570.20 over the past decade. While the company's 10-year median is 21.06 vs. the industry median of 10.55, Perrigo Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.55, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perrigo Co's current EV-to-OCF of 24.91 is 136.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perrigo Co's current EV-to-OCF is 24.91, which is 18% above median its own 10-year median of 21.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Based on GuruFocus' analysis, Perrigo Co (PRGO) is currently considered Possible Value Trap. The stock's GF Value™ is $24.91, compared to a current price of $10.43 — trading 58.1% below its estimated fair value. The current EV-to-OCF is 24.91, which is 18% above median its 10-year median of 21.06 and 136.2% above the Drug Manufacturers industry median of 10.55. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Perrigo Co (PRGO), the current EV-to-OCF is 24.91 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perrigo Co (PRGO) Overvalued in 2026?
Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued.
The current stock price of $10.43 is trading 58.1% below its estimated GF Value™ of $24.91.
GuruFocus considers Perrigo Co to be Possible Value Trap.
Key valuation signals for PRGO:
EV-to-OCF: 24.91 (18% above median its 10-year median of 21.06)
GF Value™: $24.91 vs. price of $10.43 (58.1% below fair value)
Industry Position: 136.2% above the Drug Manufacturers median (#759 of 1008)
No single metric tells the full story. See the PRGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score
Get the complete analysis for PRGO
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRGO has been successfully added to your 
